This Article Full Text Full Text (PDF) All Versions of this Article: 111/24/3255    most recent CIRCULATIONAHA.104.485029v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hua, J. Articles by Sinusas, A. J. Search for Related Content PubMed PubMed Citation Articles by Hua, J. Articles by Sinusas, A. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Nuclear Scans Related Collections Cardiovascular imaging agents/Techniques Angiogenesis Nuclear cardiology and PET

(Circulation. 2005;111:3255-3260.)
© 2005 American Heart Association, Inc.

Imaging

Noninvasive Imaging of Angiogenesis With a ^99mTc-Labeled Peptide Targeted at _vß₃ Integrin After Murine Hindlimb Ischemia

Jing Hua, MD^*; Lawrence W. Dobrucki, PhD^*; Mehran M. Sadeghi, MD; Jiasheng Zhang, MD; Brian N. Bourke, MS; Patti Cavaliere, BS; James Song, MD; Conroy Chow; Neda Jahanshad; Niels van Royen, MD, PhD; Ivo Buschmann, MD; Joseph A. Madri, MD, PhD; Marivi Mendizabal, PhD; Albert J. Sinusas, MD

From the Section of Cardiovascular Medicine, Department of Internal Medicine (J.H., L.W.D., M.M.S., J.Z., B.N.B., P.C., J.S., C.C., N.J., A.J.S.), and Department of Pathology (J.A.M.), Yale University School of Medicine, New Haven, Conn; Department of Internal Medicine III, Albert-Ludwigs University, Freiburg, Germany (J.H., N.v.R., I.B.); VA Connecticut Healthcare System, West Haven, Conn (M.M.S., J.Z.); and GE Healthcare, Buckinghamshire, UK (M.M.).

Correspondence to Albert J. Sinusas, MD, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, PO Box 208017, 3FMP, New Haven, CT 06520-8017. E-mail albert.sinusas{at}yale.edu

Received June 17, 2004; revision received February 4, 2005; accepted February 16, 2005.

Background— Noninvasive imaging strategies play a critical role in assessment of the efficacy of angiogenesis therapies. The _vß₃ integrin is activated in angiogenic vessels and represents a potential target for noninvasive imaging of angiogenesis.

Methods and Results— We evaluated a ^99mTc-labeled peptide (NC100692) targeted at _vß₃ integrin for imaging in an established murine model of angiogenesis induced by hindlimb ischemia. Control mice (n=9) or mice with surgical right femoral artery occlusion (n=29) were injected with NC100692 (1.5±0.2 mCi IV) at different times after femoral occlusion (1, 3, 7, and 14 days) for in vivo pinhole planar gamma camera imaging. Tissue from hindlimb proximal and distal to occlusion was excised for gamma well counting and for immunostaining. On in vivo pinhole images, increased focal NC100692 activity was seen distal to the occlusion at days 3 and 7. This increase in relative NC100692 activity was confirmed by gamma well counting. Lectin staining confirmed increased angiogenesis in the ischemic hindlimb at these time points. A fluorescent analogue of NC100692 was used to confirm specificity and localization of the targeted tracer in cultured endothelial cells. In addition, endothelial cell specificity was confirmed on tissue sections with the use of dual immunofluorescent staining of endothelium and the fluorescent analogue targeted at the _vß₃ integrin.

Conclusions— A ^99mTc-labeled peptide (NC100692) targeted at _vß₃ integrin selectively localized to endothelial cells in regions of increased angiogenesis and could be used for noninvasive serial "hot spot" imaging of angiogenesis. This targeted radiotracer imaging approach is a major advance in tracking therapeutic myocardial angiogenesis and has an important clinical potential.

Key Words: angiogenesis • imaging • ischemia • radioisotopes

This article has been cited by other articles:

				H. F. Langer, R. Haubner, B. J. Pichler, and M. Gawaz Radionuclide imaging a molecular key to the atherosclerotic plaque. J. Am. Coll. Cardiol., July 1, 2008; 52(1): 1 - 12. [Abstract] [Full Text] [PDF]

				L. L. Johnson, L. Schofield, T. Donahay, M. Bouchard, A. Poppas, and R. Haubner Radiolabeled Arginine-Glycine-Aspartic Acid Peptides to Image Angiogenesis in Swine Model of Hibernating Myocardium J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 500 - 510. [Abstract] [Full Text] [PDF]

				A. J. Sinusas Targeted Imaging Offers Advantages Over Physiological Imaging for Evaluation of Angiogenic Therapy J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 511 - 514. [Full Text] [PDF]

				T. Higuchi, F. M. Bengel, S. Seidl, P. Watzlowik, H. Kessler, R. Hegenloh, S. Reder, S. G. Nekolla, H. J. Wester, and M. Schwaiger Assessment of {alpha}v{beta}3 integrin expression after myocardial infarction by positron emission tomography Cardiovasc Res, May 1, 2008; 78(2): 395 - 403. [Abstract] [Full Text] [PDF]

				J. K. Willmann, K. Chen, H. Wang, R. Paulmurugan, M. Rollins, W. Cai, D. S. Wang, I. Y. Chen, O. Gheysens, M. Rodriguez-Porcel, et al. Monitoring of the Biological Response to Murine Hindlimb Ischemia With 64Cu-Labeled Vascular Endothelial Growth Factor-121 Positron Emission Tomography Circulation, February 19, 2008; 117(7): 915 - 922. [Abstract] [Full Text] [PDF]

				R. Zennadi, B. J. Moeller, E. J. Whalen, M. Batchvarova, K. Xu, S. Shan, M. Delahunty, M. W. Dewhirst, and M. J. Telen Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo Blood, October 1, 2007; 110(7): 2708 - 2717. [Abstract] [Full Text] [PDF]

				T. Bach-Gansmo, R. Danielsson, A. Saracco, B. Wilczek, T. V. Bogsrud, A. Fangberget, A. Tangerud, and D. Tobin Integrin Receptor Imaging of Breast Cancer: A Proof-of-Concept Study to Evaluate 99mTc-NC100692 J. Nucl. Med., September 1, 2006; 47(9): 1434 - 1439. [Abstract] [Full Text] [PDF]

				E. J. Suuronen, J. P. Veinot, S. Wong, V. Kapila, J. Price, M. Griffith, T. G. Mesana, and M. Ruel Tissue-Engineered Injectable Collagen-Based Matrices for Improved Cell Delivery and Vascularization of Ischemic Tissue Using CD133+ Progenitors Expanded From the Peripheral Blood Circulation, July 4, 2006; 114(1_suppl): I-138 - I-144. [Abstract] [Full Text] [PDF]

				F. A. Jaffer, P. Libby, and R. Weissleder Molecular and Cellular Imaging of Atherosclerosis: Emerging Applications J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1328 - 1338. [Abstract] [Full Text] [PDF]

				M. L. Lindsey, G. P. Escobar, L. W. Dobrucki, D. K. Goshorn, S. Bouges, J. T. Mingoia, D. M. McClister Jr., H. Su, J. Gannon, C. MacGillivray, et al. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H232 - H239. [Abstract] [Full Text] [PDF]

				F. S. Villanueva Molecular Images of Neovascularization: Art for Art's Sake or Form With a Function? Circulation, June 21, 2005; 111(24): 3188 - 3191. [Full Text] [PDF]